iFuse Implant System®

Minimally Invasive Sacroiliac Joint Surgery

iFuse Implant System®

Minimally Invasive Sacroiliac Joint Surgery

PatientsPatients

It’s time to get your life back.

Don’t let lower back pain stop you from living your life. Did you know that up to 25% of chronic lower back pain is caused by the sacroiliac joint?1 If you’re having symptoms that may be related to your sacroiliac joint, talk to your doctor about your options including the iFuse Implant System® ("iFuse"), an option for some causes of SI joint pain or dysfunction. SI joint treatment using the patented triangular design of the iFuse Implant™ has produced unparalleled clinical results. More than thirty published, peer-reviewed articles demonstrate safety and effectiveness of the iFuse Implant.2 The iFuse Implant is the only SI joint fusion device with multiple clinical studies demonstrating that treatment improved pain, patient function, and quality of life.3

For information about the risks of the iFuse Procedure, visit: www.si-bone.com/risks

Hear from people just like you.

Patient Stories
ProvidersProviders

Find out more about iFuse.

Studies show that up to 25% of chronic low back pain is sacroiliac joint in origin and that the diagnosis of sacroiliac joint disease is frequently overlooked by physicians.1 The economic burden of SI joint dysfunction among privately-insured patients in the US is substantial, highlighting the need for more cost-effective therapies.4 We’ve developed a minimally invasive sacroiliac implant system for SI joint dysfunction caused by SI joint disruptions and degenerative sacroiliitis. SI joint treatment using the patented triangular design of the iFuse Implant™ has produced unparalleled clinical results. Learn more about the published, peer-reviewed articles that demonstrate safety and effectiveness of the iFuse Procedure.2 The iFuse Implant is the only SI joint fusion device with multiple clinical studies demonstrating that treatment improved pain, patient function, and quality of life.3

 
 

For information about the risks of the iFuse Procedure, visit: www.si-bone.com/risks

  1. Cohen, Steven P. Sacroiliac Joint Pain: A Comprehensive Review of Anatomy, Diagnosis, and Treatment. Anesth Analg 2005; 101:1440-1453.
  2. Polly, D.W. et al., Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction.Int J Spine Surg. 2016; 10:Article 28.— Dr. Polly is an investigator on a clinical research study sponsored by SI-BONE. He has no financial interest in SI-BONE. Research was funded by SI-BONE, Inc. A list of additional published studies is available at www.si-bone.com/results
  3. Duhon, B* et al., Triangular Titanium Implants for Minimally Invasive Sacroiliac Joint Fusion: 2-Year Follow-Up from a Prospective Multicenter Trial. Int J Spine Surg. 2016;10:Article 13. * Paid consultant of and conducts clinical research for SI-BONE Inc.Research was funded by SI-BONE, Inc.
  4. Ackerman SJ, et al., Management of sacroiliac joint disruption and degenerative sacroiliitis with nonoperative care is medical resource-intensive and costly in the United States commercial payer population. Clinicoecon Outcomes Res 2014;6:63-74. *Research was sponsored by SI-BONE, Inc.
 

At 5 years, 82% of patients were satisfied, indicating they would have the same surgery again for the same result.

- Rudolf 2014 1

Unique Design

Triangular implants designed specifically to stabilize and fuse the heavily loaded SI joint.

Strength of Experience

More than 25,000 procedures have been performed with the iFuse Implant System - the method of choice for SI joint fusion.SM

Clinically Proven

More than thirty published, peer-reviewed articles demonstrate safety and effectiveness.2

The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks

  1. Rudolf, Leonard*. "Five-Year Clinical and Radiographic Outcomes After Minimally Invasive Sacroiliac Joint Fusion Using Triangular Implants." The Open Orthopaedics Journal. 2014;8:375-383. * Paid consultant, ownership interest, and conducts clinical research for SI-BONE Inc.Research was funded by SI-BONE, Inc.
  2. Polly, D.W. et al., Two-Year Outcomes from a Randomized Controlled Trial of Minimally Invasive Sacroiliac Joint Fusion vs. Non-Surgical Management for Sacroiliac Joint Dysfunction.Int J Spine Surg. 2016; 10:Article 28.— Dr. Polly is an investigator on a clinical research study sponsored by SI-BONE. He has no financial interest in SI-BONE. Research was funded by SI-BONE, Inc. A list of additional published studies is available at www.si-bone.com/results